Neurogene (NGNE) Amortizatization of Intangibles (2022 - 2026)
Neurogene (NGNE) posted Amortizatization of Intangibles of $7000.0 for Q1 2026, down 98.6% on a QoQ basis from $500000.0 in Q4 2025, and down 46.15% year-over-year from $13000.0 in Q1 2025.
Neurogene (NGNE) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Neurogene's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $7000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 46.15% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $531000.0 (down 78.08% YoY) and the FY2025 annual result came in at $4.5 million, up 87.52% from the prior year.
- Amortizatization of Intangibles was $7000.0 for Q1 2026 at Neurogene, down from $500000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.4 million in Q4 2024 and bottomed at -$105000.0 in Q4 2022.
- A 5-year average of $205800.0 and a median of $12000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles sank 90.74% — and 2024, when it surged 2166.67%.
- Neurogene's Amortizatization of Intangibles stood at -$105000.0 in 2022, then jumped by 200.0% to $105000.0 in 2023, then jumped by 2166.67% to $2.4 million in 2024, then tumbled by 78.99% to $500000.0 in 2025, then tumbled by 98.6% to $7000.0 in 2026.
- Business Quant data shows NGNE's Amortizatization of Intangibles at $7000.0 in Q1 2026, $500000.0 in Q4 2025, and $12000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Neurogene | 776.69 Mn | 776.69 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 2.38 Mn |
| Dec 31, 2024 | 2.38 Mn |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 105,000.00 |
| Dec 31, 2023 | 105,000.00 |